Biography

Dr. Whitaker has served as our vice president of clinical development since joining Omeros in March 2010, and served as our chief medical officer from March 2010 through August 2018 and from November 2019 to present, Dr. Whitaker served as the chief medical officer and vice president of clinical development at Allon Therapeutics, a biotechnology company focused on developing drugs for neurodegenerative diseases. From August 2007 to May 2008, he served as a medical consultant to Accelerator Corporation, a biotechnology investment and development company. From May 1994 until its acquisition by Eli Lilly and Company in 2007, Dr. Whitaker served at ICOS Corporation. At ICOS, he held roles of increasing responsibility in clinical research and medical affairs, most recently as divisional vice president of clinical research as well as medical director of the Cialis global product team. Dr. Whitaker received his M.D. from the Indiana University School of Medicine, his J.D. from the University of Washington and his B.S. from Butler University.